التفاصيل البيبلوغرافية
| العنوان: |
Health Care Workers' Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study. |
| المؤلفون: |
Borobia, Alberto M, García-García, Irene, Díaz-García, Lucía, Rodríguez-Mariblanca, Amelia, Soto, Lucía Martínez de, Villatoro, Jaime Monserrat, Meseguer, Enrique Seco, González, Juan J, Iniesta, Jesús Frías, García, Elena Ramírez, Arribas, Jose Ramón, Carcas-Sansuán, Antonio J, Martínez de Soto, Lucía, Monserrat Villatoro, Jaime, Seco Meseguer, Enrique, Frías Iniesta, Jesús, Ramírez García, Elena |
| المصدر: |
Journal of Medical Internet Research; Feb2021, Vol. 23 Issue 2, pN.PAG-N.PAG, 1p, 2 Charts |
| مصطلحات موضوعية: |
MEDICAL personnel, PANDEMICS, COVID-19, DRUG efficacy, SCIENTIFIC knowledge, SARS-CoV-2 |
| مستخلص: |
Background: In April 2020, two independent clinical trials to assess SARS-CoV-2 prophylaxis strategies among health care workers were initiated at our hospital: MeCOVID (melatonin vs placebo) and EPICOS (tenofovir disoproxil/emtricitabine vs hydroxychloroquine vs combination therapy vs placebo).Objective: This study aimed to evaluate the reasons why health care workers chose to participate in the MeCOVID and EPICOS trials, as well as why they chose one over the other.Methods: Both trials were offered to health care workers through an internal news bulletin. After an initial screening visit, all subjects were asked to respond to a web-based survey.Results: In the first month, 206 health care workers were screened and 160 were randomized. The survey participation was high at 73.3%. Health care workers cited "to contribute to scientific knowledge" (n=80, 53.0%), followed by "to avoid SARS-CoV-2 infection" (n=33, 21.9%) and "the interest to be tested for SARS-CoV-2" (n=28, 18.5%), as their primary reasons to participate in the trials. We observed significant differences in the expected personal benefits across physicians and nurses (P=.01). The vast majority of volunteers (n=202, 98.0%) selected the MeCOVID trial, their primary reason being their concern regarding adverse reactions to treatments in the EPICOS trial (n=102, 69.4%).Conclusions: Health care workers' reasons to participate in prophylaxis trials in an acute pandemic context appear to be driven largely by their desire to contribute to science and to gain health benefits. Safety outweighed efficacy when choosing between the two clinical trials. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Medical Internet Research is the property of JMIR Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Supplemental Index |
Full Text Finder